Johnson & Johnson is facing a class action lawsuit filed in California that alleges that Johnson’s Baby Powder and other baby powder products manufactured by the company can lead to a significantly increased risk of ovarian cancer. According to the lawsuit, Johnson & Johnson has known for more than 30 years that its talcum baby powder products were linked to a higher risk of ovarian cancer, but failed to warn its millions of customers about this risk.
The California class action lawsuit against Johnson & Johnson comes just one year after a jury found the company was negligent in the case of a woman who was diagnosed with ovarian cancer in 2006. Jurors ruled that Johnson & Johnson knew about the linked between talcum products such as Johnson’s Baby Powder and an increased risk of ovarian cancer.
The product labels for Johnson & Johnson’s baby powder products warn users to keep the powder away from the eyes, avoid inhalation, and to only use it externally, such as on the skin. What these labels fail to tell consumers, however, is that talcum powders such as Johnson’s Baby Powder may increase a woman’s risk of developing ovarian cancer.
According to a 1982 study, women who use talcum powder on their genital area had an increased risk of developing ovarian cancer. When contacted by a doctor at Johnson & Johnson, the author of the study told the company that it should add a warning label about the link between talcum powder and ovarian cancer to the labels of its products. However, no such warning label was added.
Further studies confirmed the link between products containing talcum powder and an increased risk of ovarian cancer. Studies have found that women who use talcum powder on their genitals were 33% more likely to develop ovarian cancer.
A 2008 study cited by the American Cancer Society found that the use of talcum products was a likely cause of increased cancer risk. According to the recent class action lawsuit, the ACS compared the use of talcum powder products to other known cancer risks, including asbestos, hormone replacement therapy, and radiation.
Find Out If You Qualify to File a Class Action Lawsuit
The attorneys at Heygood, Orr & Pearson have represented numerous plaintiffs in class action lawsuits involving consumer fraud. We have filed class action cases on behalf of investors who claim they were deceived about the value of life settlements investments purchase through other companies, and have also represented consumers who were allegedly misled by Samsung regarding the memory capacity of its Galaxy S4 phones.
Our law firm has represented individuals nationwide in class action lawsuits against some of the largest companies in the world. We believe that when consumers are the victims of corporate wrongdoing, the companies that commit these actions should be held accountable in a court of law.
In addition to the more than $200 million in verdicts and settlements that we have achieved for our clients, Heygood, Orr & Pearson has also been recognized for the exceptional quality of our attorneys and for the services they provide to our clients. Our firm has received the highest rating available from Martindale-Hubble, the top law firm rating service. Our partners—Michael Heygood, Jim Orr, and Eric Pearson—are all board certified trial lawyers* and have all been voted by their peers for several years in a row as “Super Lawyers” in the state of Texas.**
If you have been a victim of false advertising or dangerous consumer or pharmaceutical products and wish to learn more about filing a class action lawsuit, contact the law firm of Heygood, Orr & Pearson for a free consultation so we can ensure that your legal rights are protected. You can reach us by calling toll-free at 1-877-446-9001, or by following the link to our free case evaluation form.
* Michael Heygood, James Craig Orr, Jr. and Eric Pearson are all Board Certified in Personal Injury Trial Law — Texas Board of Legal Specialization.
** Michael Heygood, James Craig Orr, Jr. and Eric Pearson were selected to the Super Lawyers List, a Thomson Reuters publication, for the years 2003 through 2014.